Latest News

Earnings, dividend and buyback: what changed at Glanbia (ISE:GL9) Glanbia (ISE:GL9) has drawn fresh attention after reporting full year earnings, recommending a higher annual dividend and launching a share buyback program of up to €100 million. See our latest analysis for Glanbia. The market reaction has been broadly positive, with a 90 day share price return of 16.87% and a year to date share price return of 19.61%. The 1 year total shareholder return of 76.82% points to strong momentum...

In early March 2026, Arcutis Biotherapeutics reported strong 2025 results with revenue of US$376.07 million, a swing to quarterly profitability, raised its 2026 net product revenue guidance to US$480 million–US$495 million, advanced its ARQ-234 atopic dermatitis program into a Phase 1a/1b trial, and elevated Mas Matsuda to executive vice president, chief legal officer, and corporate secretary. Together, these developments point to a company moving from pure development-stage biotech toward a...

Repligen (RGEN) has been under pressure after a weaker February jobs report hit healthcare stocks, even as the company recently reported quarterly and full year 2025 results that showed positive revenue and net income figures. See our latest analysis for Repligen. At a share price of US$119.99, Repligen has seen a 1 day share price return of 4.03% decline, a 30 day share price return of 15.61% decline, and a 1 year total shareholder return of 22.94% decline. This suggests momentum has been...

Stanmore Resources Limited recently reported full-year 2025 results showing revenue of US$1.89 billion, down from US$2.50 billion in 2024, and a net loss of US$47.2 million compared with prior-year net income of US$191.5 million. Despite swinging to a loss, the company lifted its fully franked ordinary dividend to US$0.089 per share, signalling confidence in cash generation supported by record saleable coal production of 14.0 Mt amid earlier weather disruptions. We’ll now examine how...

Graham Holdings Company recently reported its fourth-quarter and full-year 2025 results, with quarterly sales edging up to US$1,251.02 million while net income and earnings per share from continuing operations fell sharply year over year, alongside US$10.10 million of impairment charges on intangible and other long-lived assets. The company’s decision to maintain a regular quarterly dividend of US$1.88 per share, even as full-year net income dropped significantly, highlights a continued...

Lindsay (LNN) has rolled out two new road safety products, the Road Runner Truck Mounted Attenuator and the AlphaGuard channelizing device, giving investors fresh information on its infrastructure focused portfolio. See our latest analysis for Lindsay. The recent product launches come as Lindsay's 90 day share price return of 9.67% and year to date share price return of 6.97% contrast with a 1 year total shareholder return of 0.72% decline, suggesting shorter term momentum has picked up after...

CNO Financial Group recently expanded its retirement offerings through Bankers Life’s Enhanced Death Benefit Rider for its Guaranteed Lifetime Income Annuity products, while its survey of Americans aged 50 to 85 highlighted growing concerns about inflation, longevity risk, and potential Social Security changes. Together, the new rider and survey insights underline how middle-income retirees are increasingly focused on balancing guaranteed income with the ability to leave a financial legacy...

Quarterly earnings and dividend catch investors’ attention Smith & Wesson Brands (SWBI) recently reported third quarter results alongside a fresh dividend announcement. This gives investors new data on both operating performance and direct cash returns. For the quarter ended January 31, 2026, sales were US$135.71 million compared with US$115.89 million a year earlier, while net income was US$3.75 million versus US$2.10 million. See our latest analysis for Smith & Wesson Brands. The earnings...

In February 2026, RLI Corp. completed a US$299.93 million fixed-rate senior unsecured notes offering, issuing 5.375% callable notes due June 1, 2036, alongside an amended and restated credit agreement with PNC Bank that extended maturity and expanded committed capacity. This combination of long-dated debt and enhanced bank financing reshapes RLI’s capital structure, potentially giving management more room to fund growth projects and manage liquidity across insurance cycles. Next, we’ll...

What JPMorgan Chase’s Recent Share Performance Signals for Investors JPMorgan Chase (JPM) shares have softened recently, with a 1 day return of a 1.39% decline and a roughly 10% decline over the past month. This has prompted investors to reassess what the current price may already reflect. See our latest analysis for JPMorgan Chase. The recent 1 month share price return of a 10.21% decline, alongside an 11.06% share price decline year to date from the latest share price of US$289.48,...

If you are wondering whether Interface is still good value after a strong run, this article will walk through what the current share price might be implying about the company. The stock closed at US$28.14, with a 10.6% decline over the last 7 days and an 18.7% decline over the last 30 days, while the 1 year return sits at 54.5% and the 5 year return at 102.5%. Recent news coverage around Interface has largely focused on its position in commercial flooring and modular carpet, along with how...

What Albertsons Companies (ACI) investors are reacting to now Albertsons Companies (ACI) is back on investor radars after recent trading, with the share price around $17.77 and returns mixed across time frames, including a decline over the past year and a gain over the past 3 months. See our latest analysis for Albertsons Companies. The latest move to around $17.77 follows a 1-day share price return of 2.72%, set against a 3-month share price return of 3.55% and a 1-year total shareholder...

Earlier this week, Duke Energy Corporation established a US$6.00 billion at-the-market common stock offering and related forward sale agreements to raise equity capital for grid and generation investments. The program gives Duke Energy unusual flexibility to time share issuance and manage dilution as it funds renewable projects and infrastructure upgrades. We’ll now examine how this sizeable at-the-market equity program, aimed at funding renewables and grid upgrades, reshapes Duke Energy’s...

Board meeting puts NIKKON HoldingsLtd (TSE:9072) financial policy in focus NIKKON HoldingsLtd (TSE:9072) has scheduled a March 6, 2026 board meeting to consider reversing a general reserve and to review a Notice regarding its 14th Medium-term Business Plan, drawing attention to potential shifts in capital allocation and planning. See our latest analysis for NIKKON HoldingsLtd. At a share price of ¥4,149, NIKKON HoldingsLtd has seen strong momentum, with a 13.18% 1 month share price return and...

In recent days, Thomson Reuters completed a US$1.00 billion share repurchase program, increased its buyback authorization to 16,000,000 shares for up to US$1.60 billion, filed its 2025 annual report, and announced the planned May 2026 handover of the Chief Financial Officer role from Mike Eastwood to Gary E. Bischoping, Jr. Together with a higher dividend and an additional US$605 million return-of-capital plan, these actions highlight how shareholder returns and capital allocation are...

Nurix Therapeutics recently amended its equity distribution agreement to allow sales of up to US$413.65 million of common stock through Piper Sandler under its existing shelf registration. This expanded at-the-market facility gives Nurix added funding flexibility, potentially affecting how investors assess its balance between capital needs and ownership dilution. We will now examine how this enlarged at-the-market capacity shapes Nurix’s investment narrative, particularly around funding...

The weak U.S. February jobs report, which showed an unexpected drop in employment, weighed on financial stocks as investors reassessed risk. StepStone Group (STEP) saw its share price move lower along with broader sector pressure. See our latest analysis for StepStone Group. At a last close of US$45.66, StepStone Group’s 1 day share price return of a 4.12% decline followed a weak jobs report, extending a 30 day share price return of a 26.86% decline and a year to date share price return of a...

Conference spotlight and why investors care Nextpower (NXT) is set to present at the Jefferies Power, Utilities, & Clean Energy Conference in New York on March 4, 2026. The presentation will give investors a closer look at its solar tracker business. This conference appearance follows a 46.5% rise in the share price over the past six months and years of 25% compound annual sales growth. These factors have contributed to raising Nextpower's profile on many investors' watchlists. See our latest...

Why T. Rowe Price Group is on investors’ radar T. Rowe Price Group (TROW) shares have been under pressure recently, with the stock showing negative returns over the past month, past 3 months and year to date, drawing attention to how the asset manager is currently valued. See our latest analysis for T. Rowe Price Group. At a share price of $90.40, T. Rowe Price Group has seen pressure build, with a 1 day share price return of 1.78% decline and a 90 day share price return of 13.51% decline...

In February 2026, Atlas Energy Solutions reported fourth-quarter 2025 revenue of US$249.43 million and a quarterly net loss of US$22.24 million, while full-year 2025 revenue rose to US$1.10 billion alongside a full-year net loss of US$50.30 million versus a profit the year before. Despite swinging to losses, Atlas highlighted record utilization of its Dune Express system and new initiatives in power generation aimed at broadening its revenue base beyond traditional sand and logistics. We’ll...

Savara (SVRA) is in focus after the FDA’s Day 74 Letter for MOLBREEVI indicated that no Advisory Committee meeting is planned, while parallel filings in Europe and the U.K. push its autoimmune PAP program onto a broader regulatory track. See our latest analysis for Savara. Despite the FDA letter and ongoing regulatory progress, Savara’s 1 day share price return of a 4.01% decline and 7 day share price return of a 12.46% decline point to cooling short term momentum. At the same time, the 1...

Liberty Energy overview Liberty Energy (LBRT) has drawn fresh attention after recent share price moves, with the stock showing mixed short term returns but positive momentum over the past 3 months and the past year. See our latest analysis for Liberty Energy. Despite a recent 3.7% 1 day share price decline and a 4.6% 7 day share price pullback, Liberty Energy’s 30 day share price return of 6.2% and 90 day gain of 38.1% point to building momentum that aligns with its 1 year total shareholder...

Why Mitsubishi Chemical Group is on investors’ radar Mitsubishi Chemical Group (TSE:4188) has been drawing attention after a mixed stretch in its share performance, with a small gain over the past 3 months following a decline in the past month. With the stock last closing at ¥1,037.5 and showing a 1 year total return of 34.66%, investors are weighing how its recent performance lines up with fundamentals such as revenue of ¥4.16b and net income of ¥24,079. See our latest analysis for...

In early March 2026, U.S. Bancorp completed multiple fixed-income offerings totaling more than US$90 million in senior unsecured, callable fixed-rate notes maturing between 2031 and 2046, including new 5.30% to 5.60% coupons across various tenors. These bond issues, alongside the previously announced BTIG acquisition and ongoing dividend and buyback activity, underscore U.S. Bancorp’s active use of the debt and equity markets to fund growth while fine-tuning its capital structure. We’ll now...